Literature DB >> 2406378

Labelling of hypertensives: a review of the data.

M H Alderman1, B Lamport.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2406378     DOI： 10.1016/0895-4356(90)90185-r

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN： 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  5 in total

Review 1.  Use of decision aids to support informed choices about screening.

Authors:  Alexandra Barratt; Lyndal Trevena; Heather M Davey; Kirsten McCaffery
Journal:  BMJ       Date:  2004-08-28

2.  Why is preventive medicine exempted from ethical constraints?

Authors:  P Skrabanek
Journal:  J Med Ethics       Date:  1990-12       Impact factor: 2.903

3.  Follow-up study of participants in an extensive health examination programme at a Swedish industry.

Authors:  G Rose; C Bengtsson
Journal:  Klin Wochenschr       Date:  1990-12-30

4.  Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudes.

Authors:  David K Lewis; Jude Robinson; Ewan Wilkinson
Journal:  BMJ       Date:  2003-10-11

5.  Development of an item pool for a questionnaire on the psychosocial consequences of hypertension labelling.

Authors:  János Valery Gyuricza; Ana Flávia Pires Lucas d'Oliveira; Lucas Bastos Marcondes Machado; John Brodersen
Journal:  J Patient Rep Outcomes       Date:  2019-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.